Imidara 5% Cream - Targeted Treatment for Skin Lesions
Manage skin health with precision using Imidara. This specialized treatment is designed to address specific skin conditions by leveraging your body's natural defenses, providing a professional-grade solution for localized skin concerns.
Specifications
| Active Substance | Imiquimod |
| Classification | Immune Response Modifier (IRM) |
| Manufacturer | Argis |
| Form | 12 sachets x 250 mg |
Description and Use-Case
Imidara is a topical treatment containing Imiquimod, categorized as an Immune Response Modifier (IRM). This product is designed for medical use in treating specific dermatological conditions, including:
- Superficial Basal Cell Carcinoma: Imidara is used for the treatment of superficial basal cell carcinoma, a slow-growing form of skin cancer. It is particularly useful for patients where early recognition and treatment are vital to prevent disfigurement.
- Actinic Keratosis: This treatment is suitable for flat actinic keratoses located on the face and scalp. It is intended for patients with a healthy immune system who require a targeted approach to skin lesions.
- Warts (Condylomata Acuminata): The formula is effective for treating warts located on the surface of the genitals and the perianal area.
How it works: Imidara works by stimulating your body's own immune system. By triggering a localized immune response, the active substance helps the body produce natural substances that target and fight the cells associated with basal cell carcinoma, actinic keratoses, or the viruses that cause warts. This mechanism-focused approach ensures the body’s natural defenses are working in tandem with the treatment to address skin irregularities.
Quality Assurance: As a pharmaceutical-grade product, Imidara is manufactured under strict standards, ensuring the authenticity and potency of the Imiquimod active ingredient for reliable results.